Immunotherapy Toxicities

Published Alicia Mew on

Melanoma Nursing Webinar Program

Immunotherapy toxicities: less common and rare side-effects, nurse-led assessment and management

July 17, 2025

This webinar is designed for melanoma nurses seeking to expand their knowledge of less common and rare side-effects of immunotherapy in melanoma treatment. 

While some immunotherapy toxicities are common but manageable, less common and rare side-effects can create additional complexities. This session will explore immunotherapy toxicities, and present case studies of less common and rare side-effects, discussing implications for nurses in assessment and management. 

Nurses will gain insights into nurse-led approaches and management of potentially serious or life-threatening side-effects, equipping them with the knowledge to provide comprehensive care and patient education.

Learning outcomes:

  • Recognise the spectrum of immunotherapy toxicities
  • Differentiate between less common but serious and rare but potentially life-threatening side effects
  • Discuss nursing approaches in assessing and managing less common and rare side effects
  • Equip nurses with tools and language to educate patients on recognising and reporting symptoms

Pre-reading/learning:

  • eviQ Education Module - Patient assessment and education: Immune checkpoint inhibitors for immunotherapy. 
    Please note, this module is 1.25 hours on patient assessment and education with a specific focus on irAEs

     

Speakers

Alethea Lobo

Alethea Lobo

Melanoma Clinical Nurse Consultant at Peter MacCallum Cancer Centre in Melbourne and Co-chair of the Melanoma and Skin Cancer Nurses Organisation

Alethea has extensive experience in caring for patients with all stages of melanoma, with a particular focus on the identification and management of treatment toxicities. Alethea is passionate about raising awareness of melanoma and other skin cancers amongst nurses so together they can better support patients.

 

Donna Milne

Donna Milne 
Clinical Nurse Consultant, Melanoma and Skin Cancer Service Peter MacCallum Cancer Centre

Donna's main areas of interest include management of immunotherapy and targeted therapy toxicities and supporting and educating patients with advanced cancer and their carers. Donna's PhD examined the perceptions of palliative care held by patients with advanced cancer. She was a founding co-chair of MSCNO - the Melanoma and Skin Cancer Nurses Organisation and has a Life Fellowship with CNSA.

Resource details

tiltherapymelanoma
Course type
Webinars
Duration
60 mins
Curriculum Area
Treatment (incl. Supportive Care)
Speciality
Nurse
Course Start Date
Immunotherapy
Melanoma

This course is brought to you by

Alliance members